Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael S Saporito

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Protocols in Pharmacology|September 17, 2016
A Mouse Model of Furosemide-Induced Overactive BladderMichael S Saporito, Eva Zuvich, Amy DiCamillo
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Targeting the JNK pathway for therapeutic benefit in CNS diseaseDonna Bozyczko-Coyne, Michael S Saporito, Robert L Hudkins
Progress in Medicinal Chemistry|January 9, 2003
Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseasesMichael S Saporito, Robert L Hudkins, Anna C Maroney
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2012
MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivoMichael S Saporito, Alexander R Ochman, Christopher A Lipinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2012
The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetesAlexander R Ochman, Christopher A Lipinski, Jeffrey A Handler, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2018
Intravenously Administered Ganaxolone Blocks Diazepam-Resistant Lithium-Pilocarpine-Induced Status Epilepticus in Rats: Comparison with AllopregnanoloneMichael S Saporito, John A Gruner, Amy DiCamillo, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2021
Compound FC-10696 Inhibits Egress of Marburg VirusZiying Han, Hong Ye, Jingjing Liang, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Masami Kaneko, George Gessner, et al.
Brain Research|March 17, 2004
Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cellsJoanne R Mathiasen, Beth Ann W McKenna, Michael S Saporito, et al.
Neuron|July 18, 2014
ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 miceAlipi V Naydenov, Eric A Horne, Christine S Cheah, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Protocols in Pharmacology|September 17, 2016
A Mouse Model of Furosemide-Induced Overactive BladderMichael S Saporito, Eva Zuvich, Amy DiCamillo
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Targeting the JNK pathway for therapeutic benefit in CNS diseaseDonna Bozyczko-Coyne, Michael S Saporito, Robert L Hudkins
Progress in Medicinal Chemistry|January 9, 2003
Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseasesMichael S Saporito, Robert L Hudkins, Anna C Maroney
The Journal of Pharmacology and Experimental Therapeutics|April 5, 2012
MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivoMichael S Saporito, Alexander R Ochman, Christopher A Lipinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 21, 2012
The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetesAlexander R Ochman, Christopher A Lipinski, Jeffrey A Handler, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2018
Intravenously Administered Ganaxolone Blocks Diazepam-Resistant Lithium-Pilocarpine-Induced Status Epilepticus in Rats: Comparison with AllopregnanoloneMichael S Saporito, John A Gruner, Amy DiCamillo, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2021
Compound FC-10696 Inhibits Egress of Marburg VirusZiying Han, Hong Ye, Jingjing Liang, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 2002
Mixed lineage kinase activity of indolocarbazole analoguesChikara Murakata, Masami Kaneko, George Gessner, et al.
Brain Research|March 17, 2004
Inhibition of mixed lineage kinase 3 attenuates MPP+-induced neurotoxicity in SH-SY5Y cellsJoanne R Mathiasen, Beth Ann W McKenna, Michael S Saporito, et al.
Neuron|July 18, 2014
ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 miceAlipi V Naydenov, Eric A Horne, Christine S Cheah, et al.
Pageof 2